Global pharmaceutical major GlaxoSmithKline (GSK) on Thursday announced a Rs 864 crore investment in India to set up a medicine manufacturing unit.
A new Rs 864-crore (85 million pounds) factory will be set up creating 250 jobs in India as part of our continued commitment to ensuring access to medicines for people in the country, a company release said.
During a visit to India to take part in a conference of international business leaders, GSK chief executive officer Andrew Witty said the location of the new facility is yet to be finalised, but the lead site is in Bangalore.
‘GSK is a long-standing investor in India and we fully support the government in their efforts to increase access to affordable medicines and improve healthcare.’
A new Rs 864-crore (85 million pounds) factory will be set up creating 250 jobs in India as part of our continued commitment to ensuring access to medicines for people in the country, a company release said.
During a visit to India to take part in a conference of international business leaders, GSK chief executive officer Andrew Witty said the location of the new facility is yet to be finalised, but the lead site is in Bangalore.
‘GSK is a long-standing investor in India and we fully support the government in their efforts to increase access to affordable medicines and improve healthcare.’